The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...

The 2024 Nobel Prizes in physics and chemistry were seen as a sweep for artificial intelligence (AI) tools which, at their ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.